Roth Mkm Boosts CervoMed (NASDAQ:CRVO) Price Target to $20.00
CervoMed (NASDAQ:CRVO – Get Free Report) had its target price lifted by research analysts at Roth Mkm from $15.00 to $20.00 in a note issued to investors on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Roth Mkm’s target price would indicate a potential upside of 113.45% from the stock’s previous […]
